FASN and metabolic dysfunction-associated steatotic liver disease: In view of the crucial role of FASN in aggravating the disease conditions of NAFLD, several studies have conducted targeted FASN therapy for NAFLD and found that the pharmacological inhibition of FASN activity can significantly alleviate NAFLD.